About Us Science Community Media Room Search
HIV Vaccine Awareness Day: A Message from HVTN Executive Director, Jim Kublin
Members' Site | HVTN Portal | Lab Portal
Twitter @helpendhiv




Read the latest issue of HVTNews
Immunogenicity Data Patterns Emerging from Cross Trial Comparisons
 






HIV Vaccine Awareness Day: A Message of Thanks

A message of thanks to our volunteers for their critical role in vaccine research.
(Jim Kublin, HVTN Executive Director)

Update on 505 Study

NIH discontinues immunizations in HIV vaccine study.
Read update here »

Matthew Rose, Metro WeeklyThe Search Must Continue: Halted HIV-vaccine trial may be a setback, but it's not a defeat
(May 16, 2013, Matthew Rose/MetroWeekly)
A positive outlook of the recent findings of the 505 Study.

 

 

In an Unpredictable HIV Vaccine Search, Hope Still Reigns
(May 16, 2013, Mitchell Warren/Huffington Post)
In a year that has seen both highs and lows in news from the field, it is essential to keep our sights, funding and commitment aligned with that enduring need.


Interested in Volunteering?

Different studies enroll different kinds of people at locations around the world. Contact the site near you to learn more.

  Vaccine Participants & HIV Testing
Make sure you get the right test for HIV
Information for healthcare providers

  Awards
Apply to one of our awards for minority medical students
and early stage investigators.

  Researchers:
› Do you have an idea for a study utilizing mucosal specimens?
› Would you like to submit a proposal for a study to be conducted
with the HVTN?
› Writing an article using HVTN data? See our publications policy.

Find us on:
Funded by:
Located at:
Bookmark and Share



Contact Us | Site Map | Web Policy Members' Site | HVTN Portal | Lab Portal